Effexor XR 75mg Capsules

Manufacturer PFIZER Active Ingredient Venlafaxine Extended-Release Capsules(ven la FAX een) Pronunciation ven la FAX een
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat anxiety.It is used to treat panic attacks.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Antidepressant
🧬
Pharmacologic Class
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Sep 1997
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Effexor XR is an antidepressant medication that works by affecting certain natural chemicals in the brain, specifically serotonin and norepinephrine. It's used to treat depression, anxiety disorders, and panic disorder. The 'XR' means extended-release, so it's taken once a day.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.

Take your medication with food to help your body absorb it properly.
Swallow the capsule whole - do not crush, chew, or dissolve it.
If you have trouble swallowing the capsule, you can sprinkle its contents onto a small amount of applesauce. However, do not chew the applesauce; swallow it immediately and follow with a glass of cool water.

It's essential to establish a routine when taking your medication. Take it at the same time every day, and continue taking it as directed by your doctor or healthcare provider, even if you start feeling better.

Storing and Disposing of Your Medication

To maintain the quality and safety of your medication:

Store it at room temperature in a dry place, away from the bathroom.
Keep all medications in a secure location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist.
* If you're unsure about the best way to dispose of your medication, consult your pharmacist. They may be aware of drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
πŸ’‘

Lifestyle & Tips

  • Take exactly as prescribed, usually once daily with food.
  • Swallow the capsule whole; do not crush, chew, or dissolve it.
  • If you miss a dose, take it as soon as you remember, unless it's almost time for your next dose. Do not double your dose.
  • Avoid alcohol while taking this medication, as it can worsen side effects.
  • Be aware of potential side effects like nausea, dizziness, sweating, and sexual dysfunction.
  • Do not stop taking this medication suddenly without consulting your doctor, as it can lead to withdrawal symptoms.
  • Regularly monitor your blood pressure as advised by your doctor.
  • Report any unusual changes in mood or behavior, especially suicidal thoughts, to your doctor immediately.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 75 mg orally once daily
Dose Range: 37.5 - 225 mg

Condition-Specific Dosing:

Major Depressive Disorder (MDD): Initial: 75 mg once daily. May increase by 75 mg/day increments at intervals of 4 days or more, up to 225 mg/day. Some patients may start at 37.5 mg once daily for 4-7 days before increasing to 75 mg once daily.
Generalized Anxiety Disorder (GAD): Initial: 75 mg once daily. Some patients may start at 37.5 mg once daily for 4-7 days before increasing to 75 mg once daily. Max: 225 mg/day.
Social Anxiety Disorder (SAD): Initial: 75 mg once daily. No additional benefit shown for doses above 75 mg/day.
Panic Disorder: Initial: 37.5 mg once daily for 7 days, then increase to 75 mg once daily. Max: 225 mg/day.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (Safety and efficacy not established for MDD in pediatric patients. Use generally not recommended due to increased risk of suicidal thoughts and behaviors.)
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment needed (CrCl 61-90 mL/min)
Moderate: Reduce total daily dose by 25% (CrCl 31-60 mL/min)
Severe: Reduce total daily dose by 50% (CrCl <30 mL/min)
Dialysis: Reduce total daily dose by 50% and withhold dose until end of dialysis session (administer after dialysis)

Hepatic Impairment:

Mild: Reduce total daily dose by 25% (Child-Pugh A)
Moderate: Reduce total daily dose by 50% (Child-Pugh B)
Severe: Reduce total daily dose by 50% or more (Child-Pugh C)

Pharmacology

πŸ”¬

Mechanism of Action

Venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), are potent inhibitors of neuronal serotonin and norepinephrine reuptake and a weak inhibitor of dopamine reuptake. This leads to an increase in the synaptic concentrations of these neurotransmitters in the central nervous system, thereby enhancing their neurotransmission. The antidepressant and anxiolytic effects are believed to be related to this potentiation of serotonergic and noradrenergic activity.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 45% (due to first-pass metabolism)
Tmax: Venlafaxine: 5.5 hours (extended-release); ODV: 9 hours (extended-release)
FoodEffect: Food has no significant effect on the absorption or bioavailability of venlafaxine or ODV from the extended-release capsule.

Distribution:

Vd: Approximately 7.5 L/kg
ProteinBinding: Venlafaxine: 27%; ODV: 30%
CnssPenetration: Yes

Elimination:

HalfLife: Venlafaxine: 5 Β± 2 hours; ODV: 11 Β± 2 hours
Clearance: Venlafaxine: 1.3 Β± 0.6 L/h/kg; ODV: 0.4 Β± 0.2 L/h/kg
ExcretionRoute: Renal (approximately 87% of a venlafaxine dose is recovered in the urine within 48 hours as unchanged venlafaxine, unconjugated ODV, or conjugated ODV)
Unchanged: Approximately 5% (venlafaxine); approximately 29% (ODV, unconjugated)
⏱️

Pharmacodynamics

OnsetOfAction: Initial antidepressant effects may be seen within 1-2 weeks; full therapeutic effects may take 4-6 weeks.
PeakEffect: Typically 4-6 weeks for full therapeutic effect.
DurationOfAction: Once daily dosing provides sustained therapeutic levels due to extended-release formulation and long half-life of active metabolite.

Safety & Warnings

⚠️

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thoughts and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of Effexor XR or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Effexor XR is not approved for use in pediatric patients.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of low sodium levels: headache, difficulty focusing, memory problems, confusion, weakness, seizures, or changes in balance
Signs of bleeding: vomiting or coughing up blood, vomit that resembles coffee grounds, blood in the urine, black, red, or tarry stools, bleeding from the gums, abnormal vaginal bleeding, unexplained bruises or bruises that enlarge, or uncontrollable bleeding
Signs of high blood pressure: severe headache or dizziness, fainting, or changes in vision
Seizures
Chest pain or pressure
Shortness of breath
Cough
Bone pain
Sexual problems, including decreased libido, difficulty achieving orgasm, ejaculation problems, or erectile dysfunction (if you have concerns, discuss them with your doctor)

A potentially life-threatening condition called serotonin syndrome may occur, especially if you are taking certain other medications. Seek immediate medical attention if you experience:
Agitation
Changes in balance
Confusion
Hallucinations
Fever
Rapid or abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea, nausea, or vomiting
Severe headache

Other Possible Side Effects

As with any medication, you may experience side effects. While many people have no side effects or only mild ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:

Difficulty sleeping
Feeling nervous, anxious, or excitable
Anxiety
Weight loss
Dizziness, drowsiness, fatigue, or weakness
Shakiness
Headache
Excessive sweating
Constipation, diarrhea, nausea, vomiting, or decreased appetite
Gas
Dry mouth
Vivid or unusual dreams
Yawning

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or anxiety
  • Thoughts of self-harm or suicide
  • New or severe agitation, restlessness, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity
  • Mania or hypomania (e.g., racing thoughts, increased energy, severe trouble sleeping)
  • Signs of serotonin syndrome (e.g., confusion, hallucinations, rapid heart rate, sweating, muscle stiffness, tremors, severe nausea/vomiting/diarrhea)
  • Unusual bleeding or bruising
  • Severe eye pain, blurred vision, or seeing halos around lights (signs of acute narrow-angle glaucoma)
  • Seizures
  • Significant increase in blood pressure
  • Allergic reaction (e.g., rash, hives, swelling of face/lips/tongue, difficulty breathing)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions and situations to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reactions you experienced.
If you have high blood pressure, as this medication may affect your condition.
If you have narrow-angle glaucoma, a condition that affects the pressure in your eyes.
If you are taking a weight loss drug, as this may interact with the medication.
If you are taking or have recently taken certain medications, including:
+ Linezolid or methylene blue, as these can cause serious interactions.
+ Certain drugs for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, within the last 14 days. This is crucial because combining these medications can lead to very high blood pressure.

Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is vital to:

Inform your doctor and pharmacist about all your medications, including prescription and over-the-counter drugs, natural products, and vitamins.
Discuss your health problems with your doctor to verify that it is safe to take this medication with your existing conditions and treatments.
Never start, stop, or change the dose of any medication without consulting your doctor first.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Before engaging in activities that require alertness, such as driving, wait until you understand how this drug affects you.

To minimize the risk of severe side effects, do not abruptly stop taking this medication without consulting your doctor. If you need to discontinue use, your doctor will instruct you on how to gradually stop taking it. Be sure to discuss any new or worsening symptoms with your doctor.

Monitor your blood pressure regularly, as this medication can cause high blood pressure. Your doctor will advise you on the frequency of blood pressure checks.

Avoid consuming alcohol while taking this medication. Additionally, consult your doctor before using marijuana, cannabis, or prescription or over-the-counter drugs that may cause drowsiness.

Be aware that this medication may increase the risk of bleeding, which can be life-threatening in some cases. Discuss this risk with your doctor.

If you have bipolar disorder, be cautious of manic episodes while taking this medication. Immediately contact your doctor if you experience symptoms of a manic episode.

Some individuals may be at a higher risk of eye problems while taking this medication. Your doctor may recommend an eye exam to assess this risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, contact your doctor promptly.

This medication can cause low blood sodium levels, which can be fatal in severe cases. Discuss this risk with your doctor.

High cholesterol has been associated with this medication. If you have concerns, consult your doctor.

This medication may affect certain laboratory tests. Inform all your healthcare providers and laboratory personnel that you are taking this medication.

You may notice remnants of the medication in your stool, but this is normal and not a cause for concern. If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

In some cases, this medication may affect growth in children and teenagers. They may require regular growth checks, so discuss this with your doctor.

If you are pregnant, plan to become pregnant, or are breastfeeding, consult your doctor to discuss the benefits and risks of taking this medication. Taking this medication in mid to late pregnancy may lead to health problems in the mother, such as postpartum bleeding, or the newborn. Breastfeeding mothers should discuss potential risks to their baby with their doctor.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Somnolence
  • Mild tremor
  • Nausea
  • Vomiting
  • Dizziness
  • Tachycardia
  • Mydriasis
  • Seizures
  • ECG changes (e.g., QT prolongation, QRS prolongation)
  • Serotonin syndrome
  • Coma

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. There is no specific antidote. Treatment is supportive and symptomatic, including maintaining an adequate airway, oxygenation, and ventilation. Activated charcoal may be considered if ingested recently. Monitor cardiac rhythm and vital signs.

Drug Interactions

🚫

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) (concurrent use or within 14 days of discontinuing MAOI, or within 7 days of discontinuing venlafaxine before starting MAOI) - risk of serotonin syndrome.
πŸ”΄

Major Interactions

  • Other serotonergic drugs (e.g., triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, St. John's Wort, other SNRIs/SSRIs) - increased risk of serotonin syndrome.
  • Linezolid, Methylene Blue (IV) - risk of serotonin syndrome.
  • Drugs that prolong the QT interval (e.g., Class IA and III antiarrhythmics, antipsychotics, macrolide antibiotics, fluoroquinolone antibiotics) - potential for QT prolongation.
  • Warfarin - increased risk of bleeding.
  • Drugs affecting CYP2D6 (e.g., quinidine, fluoxetine, paroxetine) - may increase venlafaxine levels and/or ODV levels, potentially increasing adverse effects.
🟑

Moderate Interactions

  • Alcohol - may impair psychomotor skills.
  • Cimetidine - may inhibit first-pass metabolism of venlafaxine, increasing venlafaxine AUC.
  • Haloperidol, Risperidone - venlafaxine may increase plasma levels of these antipsychotics.
  • Indinavir - venlafaxine may decrease indinavir AUC.
  • Metoprolol - venlafaxine may increase metoprolol AUC and Cmax.
🟒

Minor Interactions

  • Not specifically categorized as minor, but general caution with CNS depressants.

Monitoring

πŸ”¬

Baseline Monitoring

Blood Pressure

Rationale: Venlafaxine can cause dose-related sustained increases in blood pressure.

Timing: Prior to initiation of therapy.

Heart Rate

Rationale: Can cause increases in heart rate.

Timing: Prior to initiation of therapy.

Weight

Rationale: Changes in weight can occur.

Timing: Prior to initiation of therapy.

Sodium (Na+)

Rationale: Risk of hyponatremia, especially in elderly or volume-depleted patients.

Timing: Prior to initiation, especially in at-risk patients.

Suicidality Risk Assessment

Rationale: Increased risk of suicidal thoughts and behaviors, especially in children, adolescents, and young adults.

Timing: Prior to initiation and throughout treatment.

Personal/Family History of Mania/Hypomania

Rationale: Risk of activating mania/hypomania in patients with bipolar disorder.

Timing: Prior to initiation.

Glaucoma Assessment (narrow-angle)

Rationale: Risk of mydriasis and acute narrow-angle glaucoma attack.

Timing: Prior to initiation in patients at risk.

πŸ“Š

Routine Monitoring

Blood Pressure

Frequency: Regularly, especially during dose titration and periodically thereafter.

Target: Maintain within normal limits; individualize based on patient.

Action Threshold: Significant or sustained elevation (e.g., >140/90 mmHg) may require dose reduction or discontinuation.

Heart Rate

Frequency: Periodically.

Target: Normal range.

Action Threshold: Persistent tachycardia.

Weight

Frequency: Periodically.

Target: Stable or within healthy range.

Action Threshold: Significant or undesirable weight changes.

Sodium (Na+)

Frequency: Periodically, especially in elderly or those on diuretics.

Target: 135-145 mEq/L.

Action Threshold: <135 mEq/L (hyponatremia).

Mental Status/Behavioral Changes

Frequency: Frequent monitoring, especially during initial therapy and dose changes.

Target: Improvement in target symptoms without emergence of new or worsening psychiatric symptoms.

Action Threshold: Worsening depression, emergence of suicidal ideation/behavior, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, akathisia, hypomania, mania.

Serotonin Syndrome Symptoms

Frequency: Ongoing, especially with concomitant serotonergic drugs.

Target: Absence of symptoms.

Action Threshold: Agitation, hallucinations, delirium, coma, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, tremor, rigidity, myoclonus, hyperreflexia, incoordination, GI symptoms.

Bleeding/Bruising

Frequency: Ongoing, especially with concomitant anticoagulants/antiplatelets.

Target: Absence of abnormal bleeding.

Action Threshold: Unexplained bruising, petechiae, purpura, GI bleeding.

πŸ‘οΈ

Symptom Monitoring

  • Worsening depression
  • Suicidal thoughts or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, hostility, impulsivity)
  • Panic attacks
  • Insomnia
  • New or worsening anxiety
  • Restlessness
  • Akathisia (psychomotor restlessness)
  • Hypomania
  • Mania
  • Serotonin syndrome symptoms (e.g., fever, sweating, confusion, muscle rigidity, tremors, rapid heart rate)
  • Abnormal bleeding or bruising
  • New or worsening eye pain, blurred vision, or halos around lights (signs of acute narrow-angle glaucoma)
  • Seizures
  • Sexual dysfunction
  • Nausea, vomiting, diarrhea, constipation
  • Dizziness, headache
  • Dry mouth
  • Sweating
  • Tremor

Special Patient Groups

🀰

Pregnancy

Use during pregnancy should be considered only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to SNRIs/SSRIs late in the third trimester have developed complications requiring prolonged hospitalization, respiratory support, and tube feeding. These complications can arise immediately upon delivery.

Trimester-Specific Risks:

First Trimester: Limited data, but generally not associated with major congenital malformations.
Second Trimester: No specific increased risks identified beyond general antidepressant use.
Third Trimester: Increased risk of persistent pulmonary hypertension of the newborn (PPHN) and neonatal withdrawal syndrome (e.g., respiratory distress, feeding difficulties, irritability, tremor, hypotonia, seizures).
🀱

Lactation

Venlafaxine and its active metabolite (ODV) are excreted into human milk. The decision to breastfeed should consider the developmental and health benefits of breastfeeding, the mother’s clinical need for Effexor XR, and any potential adverse effects on the breastfed infant from Effexor XR or from the underlying maternal condition. Monitor breastfed infants for sedation, poor feeding, and poor weight gain.

Infant Risk: L3 (Moderate risk) - Monitor infant for adverse effects.
πŸ‘Ά

Pediatric Use

Safety and efficacy have not been established in pediatric patients. Antidepressants, including venlafaxine, increase the risk of suicidal thoughts and behavior in children, adolescents, and young adults (aged 18-24) compared to placebo. Use is generally not recommended.

πŸ‘΄

Geriatric Use

No overall differences in effectiveness were observed between geriatric and younger patients. However, elderly patients may be more sensitive to the effects of venlafaxine, particularly hyponatremia and orthostatic hypotension. Dosage adjustments may be necessary, especially in those with renal or hepatic impairment. Start with lower doses and titrate slowly.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Effexor XR capsules contain spheroids that release venlafaxine slowly. Patients may notice these 'ghost' capsules in their stool, which is normal and does not mean the medication was not absorbed.
  • Venlafaxine has a dose-dependent effect on norepinephrine reuptake; lower doses primarily affect serotonin, while higher doses also significantly affect norepinephrine.
  • Discontinuation syndrome (withdrawal) is common and can be severe with venlafaxine due to its relatively short half-life compared to some other antidepressants. Tapering should be gradual, typically over several weeks, and individualized.
  • Monitor blood pressure regularly, especially during dose escalation, as venlafaxine can cause sustained hypertension.
  • Caution is advised in patients with a history of seizures, narrow-angle glaucoma, or cardiovascular disease.
  • Sexual dysfunction (e.g., decreased libido, anorgasmia, ejaculatory delay) is a common side effect and should be discussed with patients.
πŸ”„

Alternative Therapies

  • Other SNRIs (e.g., duloxetine, desvenlafaxine, levomilnacipran)
  • SSRIs (e.g., fluoxetine, sertraline, paroxetine, citalopram, escitalopram)
  • Atypical antidepressants (e.g., bupropion, mirtazapine, trazodone)
  • Tricyclic Antidepressants (TCAs) (e.g., amitriptyline, nortriptyline)
  • MAOIs (e.g., phenelzine, tranylcypromine, selegiline)
  • Psychotherapy (e.g., Cognitive Behavioral Therapy - CBT)
  • Electroconvulsive Therapy (ECT) for severe depression
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $100-$300+ per 30 capsules (75mg)
Generic Available: Yes
Insurance Coverage: Most insurance plans cover generic venlafaxine XR, often as a Tier 1 or Tier 2 medication. Brand name Effexor XR may be Tier 3 or require prior authorization.
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which provides crucial information for patients. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider for guidance. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the overdose, including the medication taken, the amount, and the time it occurred.